本季度信息
根据公告，微创医疗（00853）合并报表已纳入其持股40.32%的子公司上海微创心脉医疗科技（集团）股份有限公司的业绩。报告期内（截至2026年6月30日止六个月），该子公司实现收入7.94亿元，同比增长11.13%；净利润为3.22亿元，同比增长2.45%。同时，心脉医疗科技总资产达49.57亿元，较2025年12月31日增长6.80%，归属心脉医疗科技股权持有人的总权益为42.58亿元，同比上升4.472%。
本季度信息
根据公告，微创医疗（00853）合并报表已纳入其持股40.32%的子公司上海微创心脉医疗科技（集团）股份有限公司的业绩。报告期内（截至2026年6月30日止六个月），该子公司实现收入7.94亿元，同比增长11.13%；净利润为3.22亿元，同比增长2.45%。同时，心脉医疗科技总资产达49.57亿元，较2025年12月31日增长6.80%，归属心脉医疗科技股权持有人的总权益为42.58亿元，同比上升4.472%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.